oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2020 ( 6 )

2019 ( 798 )

2018 ( 1109 )

2017 ( 1052 )

Custom range...

Search Results: 1 - 10 of 594322 matches for " Lía Schwartz Lerner "
All listed articles are free for downloading (OA Articles)
Page 1 /594322
Display every page Item
Ilse Nolting-Hauff. Visión, sátira y agudeza en los "Sue os" de Quevedo. Madrid (Editorial Gredos) 1974.
Lía Schwartz Lerner
Lexis , 1978,
Abstract:
En torno a la enunciación en la sátira: los casos de El Crotalon y los Sue os de Quevedo
Lía Schwartz Lerner
Lexis , 1985,
Abstract: En el marco de las teorías actuales de la literatura resulta problemática la clasificación de la sátira como forma literaria. No lo era en el ámbito de la literatura latina, en el que la satura constituía un género perfectamente identificado para sus receptores y, por ello, podía ser definida en sus rasgos esenciales. El corpus clásico de sátiras incluía dos variantes: la satura en hexámetros y la sátira menipea que podía combinar prosa y verso. El concepto de satura parece ya circunscripto en un texto de Lucilio. Pero sin duda Horacio explicita las normas del género literario que escoge en, por lo menos, tres ocasiones: dos en sus sermones 1,4, 1-4, donde cita a Lucilio y establece los antecedentes griegos del género romano y II, 1, sobre la necesidad de escribir sátiras- una en su EpistuJae, II,2,58-60; A partir de Horacío, por lo tanto, la satura se presenta como realización histórica de un tipo de discurso literario, es decir, como un género definido por convenciones propias según el modelo ya ofrecido por Lucilio 1 Sin duda, los tratadistas romanos reconocían la influencia de obras satíricas griegas en los escritores de Saturae. Pero Quintiliano no vacila en se alar el carácter de novedad genérica de la sátira en verso; por ello excluye la posibilidad de un prototipo griego: "satura. . . tota nostra est." (lnstitutio oratoria, 10,1,95).
IGNACIO ARELLANO, Poesía satírico burlesca de Quevedo: estudio y anotación filológica de los sonetos
Lía Schwartz Lerner
Lexis , 1986,
Abstract: Es éste uno de los libros de conjunto más completos que se hayan escrito sobre la poesía satírica de Quevedo. La seriedad de la empresa y la riqueza de datos que ofrece al estudioso de la obra de Quevedo y de la poesía barroca en general aseguran su valor y su éxito.
Edmond Cros, L'Aristocrate et le Carnaval des Gueux. Etude sur le "Buscón" de Quevedo, Montpellier (E tu des Socio critiques) 197 5, 121 pp.
Lía Schwartz Lerner
Lexis , 1977,
Abstract:
Supervivencia y variación de imágenes clásicas en la obra satírica de Quevedo
Lía Schwartz Lerner
Lexis , 1978,
Abstract: No presenta resúmen
Novos registros e amplia??o de limites meridionais de distribui??o de poríferos (Porifera, Demospongiae) no Atlantico sudoeste
Lerner, Cléa;Mothes, Beatriz;Carraro, Jo?o L.;
Revista Brasileira de Zoologia , 2005, DOI: 10.1590/S0101-81752005000300012
Abstract: the southern boundaries of seven species of brazilian coast sponges were enlarged. two of them represent new records: chalinula zeae de weerdt, 2000 e terpios manglaris rützler & smith, 1993 and five were registered for the first time from the state of santa catarina: callyspongia (toxochalina) pseudotoxa muricy & ribeiro, 1999; mycale (carmia) magnirhaphidifera van soest, 1984; hymeniacidon heliophila parker, 1910; monanchora arbuscula (duchassaing & michelotti, 1864) and scopalina ruetzleri (wiedenmayer, 1977). the taxonomic description of species is also provided and the three latter were described for the first time from the brazilian coast, since other authors only cited it.
Spectral statistics in disordered metals: a trajectories approach
Robert A. Smith,Igor V. Lerner,Boris L. Altshuler
Physics , 1998, DOI: 10.1103/PhysRevB.58.10343
Abstract: We show that the perturbative expansion of the two-level correlation function, $R(\omega)$, in disordered conductors can be understood semiclassically in terms of self-intersecting particle trajectories. This requires the extension of the standard diagonal approximation to include pairs of paths which are non-identical but have almost identical action. The number of diagrams thus produced is much smaller than in a standard field-theoretical approach. We show that such a simplification occurs because $R(\omega)$ has a natural representation as the second derivative of free energy $F(\omega)$. We calculate $R(\omega)$ to 3-loop order, and verify a one-parameter scaling hypothesis for it in 2d. We discuss the possibility of applying our ``weak diagonal approximation'' to generic chaotic systems.
Theoretical Study of 5-HTP. Potential New Drug Resulting from the Complexation of 5-HTP with ATP  [PDF]
Josette Weinberg, Dan A. Lerner
Computational Chemistry (CC) , 2013, DOI: 10.4236/cc.2013.11001
Abstract: 5-HTP (5-Hydroxytryptophan), is the precursor of the neurotransmitter serotonin. Molecular parameters (interatomic distances and angles, total atomic charge, dipole moments) of 5-HTP (5-Hydroxytryptophan) and ATP (Adenosine triphosphate), and of their possible complex, including its heat of formation, have been computed in an ab initio study involving DFT calculations. The 6-31G* basis set and the B3LYP functional were employed. The aim of this study is to emphasize by DFT calculation the possible existence of a complex between ATP and 5-HTP that may have the properties of a new drug. A Natural Bond Orbital analysis description offers supplementary details for the structure of the molecular units and their interaction.
Memantine as an Augmentation Therapy for Anxiety Disorders
Thomas L. Schwartz,Umar A. Siddiqui,Shafi Raza
Case Reports in Psychiatry , 2012, DOI: 10.1155/2012/749796
Abstract: Objective. Glutamate, an excitatory neurotransmitter in the central nervous system (CNS), may play a role in the development of anxiety. Memantine partially blocks N-methyl-D-aspartate (NMDA) receptors' glutamate channels located in the CNS. This paper evaluates memantine as an augmentation therapy for treatment of anxiety. Methods. 15 consecutive partially responding anxious patients were treated with adjunctive memantine for 10 weeks. Memantine was dosed 5–20 mg/day. Result. Memantine augmentation resulted in clinically relevant reduction in anxiety symptoms when compared to baseline. Forty percent of patients achieved remission (HAM-A ≥ 7). Memantine improved sleep quality. Mean dose was 14 mg/d (range 5–20 mg/d). Typical adverse events included nausea and headache. Conclusion. The NMDA receptor antagonist memantine may be an effective augmentation therapy in patients with treatment-resistant anxiety.
The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer
J. L. Schwartz,A. N. Shajahan,R. Clarke
International Journal of Breast Cancer , 2011, DOI: 10.4061/2011/912102
Abstract: Resistance to endocrine therapy is common among breast cancer patients with estrogen receptor alpha-positive (ER+) tumors and limits the success of this therapeutic strategy. While the mechanisms that regulate endocrine responsiveness and cell fate are not fully understood, interferon regulatory factor-1 (IRF1) is strongly implicated as a key regulatory node in the underlying signaling network. IRF1 is a tumor suppressor that mediates cell fate by facilitating apoptosis and can do so with or without functional p53. Expression of IRF1 is downregulated in endocrine-resistant breast cancer cells, protecting these cells from IRF1-induced inhibition of proliferation and/or induction of cell death. Nonetheless, when IRF1 expression is induced following IFNγ treatment, antiestrogen sensitivity is restored by a process that includes the inhibition of prosurvival BCL2 family members and caspase activation. These data suggest that a combination of endocrine therapy and compounds that effectively induce IRF1 expression may be useful for the treatment of many ER+ breast cancers. By understanding IRF1 signaling in the context of endocrine responsiveness, we may be able to develop novel therapeutic strategies and better predict how patients will respond to endocrine therapy. 1. Introduction of Breast Cancer and Antiestrogens The American Cancer Society estimates that in 2010, 207,090 women were diagnosed with invasive breast cancer, and approximately 40,000 women died from the disease in the United States alone [1]. Despite the advances in treatment, earlier detection through screening, and increased awareness, breast cancer remains the second most diagnosed cancer in women [2]. Approximately 70% of tumors will be estrogen receptor- positive (ER+). Randomized trials and large meta-analyses clearly indicate that all breast cancer patients derive a statistically significant survival benefit from endocrine therapy and chemotherapy [3], with the antiestrogen (AE) tamoxifen (TAM) being among the most effective single agents. This survival benefit reflects the ability of these agents to drive cells down an irreversible cell death pathway [4]. Yet, advanced ER+ breast cancer remains an incurable disease, and improvements in overall survival rates for these women have been relatively modest during this timeframe [5]. Endocrine therapy is generally administered as an antiestrogen, such as TAM or fulvestrant (FAS; Faslodex; ICI 182,780), or as an aromatase inhibitor (AI) including letrozole or exemestane. TAM is the most frequently used AE and significantly reduces the risk of
Page 1 /594322
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.